MDNC
Medinotec Inc.
Price Chart
Latest Quote
$5.00
+0.00 (+0.00%)
Current Price
| Previous Close | $5.00 |
| Open | $5.00 |
| Day High | $5.00 |
| Day Low | $5.00 |
| Volume | 100 |
Stock Information
| Shares Outstanding | 11.76M |
| Total Debt | $15K |
| Cash Equivalents | $2.76M |
| Revenue | $9.73M |
| Net Income | $795K |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $58.78M |
| P/E Ratio | 27.78 |
| EPS (TTM) | $0.18 |
| Exchange | OQX |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $56.04M |
| Sales | $9.73M |
| Income | $795K |
| Book/sh | $0.49 |
| Cash/sh | $0.23 |
| Employees | 36 |
Financial Ratios
| Quick Ratio | 4.66 |
| Current Ratio | 5.83 |
| Debt/Eq | 0.27 |
Returns & Margins
| ROA | 10.04% |
| ROE | 15.92% |
| Gross Margin | 52.71% |
| Operating Margin | -14.50% |
| Profit Margin | 8.17% |
Ownership
| Insider Ownership | 84.43% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 6.04 |
| P/B | 10.29 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $5.00 |
| SMA50 | $5.00 |
| SMA200 | $5.00 |
| RSI | nan |
| Shares Float | 1.81M |
Performance History
| Week | +0.00% |
| Month | +0.00% |
| Quarter | +0.00% |
| 6 Months | +0.00% |
| YTD | +0.00% |
| Year | +0.00% |
| 10 Years | +0.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $5.00 | 0 |
| 2026-06-23 | $5.00 | 0 |
| 2026-06-22 | $5.00 | 0 |
| 2026-06-18 | $5.00 | 0 |
| 2026-06-17 | $5.00 | 0 |
| 2026-06-16 | $5.00 | 0 |
| 2026-06-15 | $5.00 | 0 |
| 2026-06-12 | $5.00 | 0 |
| 2026-06-11 | $5.00 | 0 |
| 2026-06-10 | $5.00 | 0 |
| 2026-06-09 | $5.00 | 0 |
| 2026-06-08 | $5.00 | 0 |
| 2026-06-05 | $5.00 | 0 |
| 2026-06-04 | $5.00 | 0 |
| 2026-06-03 | $5.00 | 0 |
| 2026-06-02 | $5.00 | 0 |
| 2026-06-01 | $5.00 | 0 |
| 2026-05-29 | $5.00 | 0 |
| 2026-05-28 | $5.00 | 0 |
| 2026-05-27 | $5.00 | 0 |
| 2026-05-26 | $5.00 | 0 |
About Medinotec Inc.
Medinotec Inc. engages in the research and development, production, and sale of medical devices used in cardiology and airway-related procedures in South Africa, the United States, and internationally. The company offers semi-compliant percutaneous transluminal coronary angioplasty balloon catheters, suction dissectors, aortic perfusion and dilation catheters, chronic total occlusion catheters, and silicone tracheal stents; and distributes a range of cardiology and renal dialysis products. It serves hospitals, clinics, third-party healthcare providers, distributors, and other institutions, including governmental healthcare programs and group purchasing organizations. The company sells its products through the network of distributors and direct sales force. Medinotec Inc. was incorporated in 2021 and is headquartered in Johannesburg, South Africa.
đ° Latest News
No news articles available at the moment. Check back later for updates on MDNC.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-02-28 | 2024-02-29 | 2023-02-28 |
|---|---|---|---|
| Revenue | |||
| Reconciled Cost Of Revenue | $4,252,821 | $2,553,645 | $417,757 |
| Cost Of Revenue | $4,252,821 | $2,577,922 | $417,757 |
| Total Revenue | $9,113,607 | $5,020,391 | $999,579 |
| Operating Revenue | $9,113,607 | $5,020,391 | $999,579 |
| Expenses | |||
| Interest Expense | $176,416 | $277,230 | $226,814 |
| Total Expenses | $5,922,108 | $5,061,825 | $1,238,166 |
| Other Income Expense | $387 | $4,304 | $51,417 |
| Other Non Operating Income Expenses | $387 | $4,304 | $51,417 |
| Net Non Operating Interest Income Expense | $-167,748 | $-216,640 | $-204,307 |
| Interest Expense Non Operating | $176,416 | $277,230 | $226,814 |
| Operating Expense | $1,669,287 | $2,483,903 | $820,409 |
| Selling And Marketing Expense | $113,194 | $84,564 | $53,818 |
| General And Administrative Expense | $1,391,114 | $1,671,028 | $648,172 |
| Income & Earnings | |||
| Net Income From Continuing Operation Net Minority Interest | $2,159,473 | $-404,688 | $-352,735 |
| Net Interest Income | $-167,748 | $-216,640 | $-204,307 |
| Interest Income | $8,668 | $60,590 | $22,507 |
| Normalized Income | $2,159,473 | $-404,688 | $-352,735 |
| Net Income From Continuing And Discontinued Operation | $2,159,473 | $-404,688 | $-352,735 |
| Total Operating Income As Reported | $3,191,499 | $600,578 | $-238,587 |
| Net Income Common Stockholders | $2,159,473 | $-404,688 | $-352,735 |
| Net Income | $2,159,473 | $-404,688 | $-352,735 |
| Net Income Including Noncontrolling Interests | $2,159,473 | $-404,688 | $-352,735 |
| Net Income Continuous Operations | $2,159,473 | $-404,688 | $-352,735 |
| Pretax Income | $3,024,138 | $-253,770 | $-391,477 |
| Interest Income Non Operating | $8,668 | $60,590 | $22,507 |
| Operating Income | $3,191,499 | $-41,434 | $-238,587 |
| Depreciation Amortization Depletion Income Statement | $73,846 | $63,948 | $53,553 |
| Depreciation And Amortization In Income Statement | $73,846 | $63,948 | $53,553 |
| Gross Profit | $4,860,786 | $2,442,469 | $581,822 |
| Depreciation Income Statement | - | $63,948 | $53,553 |
| Per Share | |||
| Diluted EPS | $0.18 | $-0.03 | $-0.03 |
| Basic EPS | $0.18 | $-0.03 | $-0.03 |
| Other | |||
| Tax Effect Of Unusual Items | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $3,274,400 | $111,685 | $-111,110 |
| Reconciled Depreciation | $73,846 | $88,225 | $53,553 |
| EBITDA (Bullshit earnings) | $3,274,400 | $111,685 | $-111,110 |
| EBIT | $3,200,554 | $23,460 | $-164,663 |
| Diluted Average Shares | $11,733,750 | $11,733,750 | $11,733,750 |
| Basic Average Shares | $11,733,750 | $11,733,750 | $11,733,750 |
| Diluted NI Availto Com Stockholders | $2,159,473 | $-404,688 | $-352,735 |
| Tax Provision | $864,665 | $150,918 | $-38,742 |
| Provision For Doubtful Accounts | $0 | $642,012 | $0 |
| Research And Development | $91,133 | $22,351 | $64,866 |
| Selling General And Administration | $1,504,308 | $1,755,592 | $701,990 |
| Other Gand A | $1,391,114 | $1,671,028 | $648,172 |
Fetched: 2026-02-06
Balance Sheet (Annual)
| Metric | 2025-02-28 | 2024-02-29 | 2023-02-28 | 2022-02-28 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $4,270,829 | $2,167,171 | $2,556,055 | $-469,985 |
| Total Assets | $6,808,973 | $4,804,279 | $4,490,432 | $1,323,031 |
| Total Non Current Assets | $385,787 | $424,982 | $1,120,954 | $601,329 |
| Non Current Deferred Assets | $0 | $42,881 | $108,951 | $85,626 |
| Non Current Deferred Taxes Assets | $0 | $42,881 | $108,951 | $85,626 |
| Non Current Note Receivables | $0 | $0 | $605,130 | $0 |
| Current Assets | $6,423,186 | $4,379,297 | $3,369,478 | $721,702 |
| Prepaid Assets | $51,086 | $42,571 | - | - |
| Inventory | $988,341 | $863,452 | $354,304 | $438,923 |
| Receivables | $2,614,073 | $664,364 | $21,074 | $42,183 |
| Other Receivables | $1,633 | $74,603 | - | - |
| Accounts Receivable | $2,612,440 | $589,761 | $21,074 | $42,183 |
| Allowance For Doubtful Accounts Receivable | $-69,921 | $-51,606 | - | - |
| Gross Accounts Receivable | $2,682,361 | $641,367 | - | - |
| Cash Cash Equivalents And Short Term Investments | $2,769,686 | $2,808,910 | $2,827,457 | $131,577 |
| Cash And Cash Equivalents | $2,769,686 | $2,808,910 | $2,827,457 | $131,577 |
| Cash Financial | $2,769,686 | $2,808,910 | $2,827,457 | $131,577 |
| Other Current Assets | - | $117,174 | $166,643 | $109,019 |
| Debt | ||||
| Total Debt | $981,033 | $1,833,971 | $1,863,066 | $1,583,997 |
| Long Term Debt And Capital Lease Obligation | $952,973 | $1,809,655 | $1,863,066 | $1,583,997 |
| Long Term Debt | $940,277 | $1,769,957 | $1,863,066 | $1,583,997 |
| Current Debt And Capital Lease Obligation | $28,060 | $24,316 | - | - |
| Net Debt | - | - | - | $1,452,420 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $2,538,144 | $2,637,108 | $1,934,377 | $1,793,016 |
| Total Non Current Liabilities Net Minority Interest | $1,033,097 | $1,809,655 | $1,863,066 | $1,583,998 |
| Non Current Deferred Liabilities | $80,124 | $0 | - | - |
| Non Current Deferred Taxes Liabilities | $80,124 | $0 | - | - |
| Current Liabilities | $1,505,047 | $827,453 | $71,311 | $209,018 |
| Payables And Accrued Expenses | $1,476,987 | $711,137 | $71,311 | $208,835 |
| Payables | $1,467,331 | $699,453 | $64,316 | $200,121 |
| Other Payable | $73,341 | $55,580 | $10,701 | $39,434 |
| Total Tax Payable | $195,037 | $53,646 | $0 | - |
| Accounts Payable | $1,198,953 | $588,640 | $53,615 | $160,687 |
| Current Deferred Liabilities | - | - | $0 | $183 |
| Other Non Current Liabilities | - | - | - | $1 |
| Equity | ||||
| Common Stock Equity | $4,270,829 | $2,167,171 | $2,556,055 | $-469,985 |
| Total Equity Gross Minority Interest | $4,270,829 | $2,167,171 | $2,556,055 | $-469,985 |
| Stockholders Equity | $4,270,829 | $2,167,171 | $2,556,055 | $-469,985 |
| Gains Losses Not Affecting Retained Earnings | $44,589 | $100,371 | $84,567 | $3,917 |
| Other Equity Adjustments | $44,589 | $100,371 | $84,567 | $3,917 |
| Retained Earnings | $918,115 | $-1,241,325 | $-836,637 | $-483,902 |
| Other | ||||
| Ordinary Shares Number | $11,733,750 | $11,733,750 | $11,733,750 | $11,733,750 |
| Share Issued | $11,733,750 | $11,733,750 | $11,733,750 | $11,733,750 |
| Tangible Book Value | $4,270,829 | $2,167,171 | $2,556,055 | $-469,985 |
| Invested Capital | $5,211,106 | $3,937,128 | $4,419,121 | $1,114,012 |
| Working Capital | $4,918,139 | $3,551,844 | $3,298,167 | $512,684 |
| Capital Lease Obligations | $40,756 | $64,014 | $0 | - |
| Total Capitalization | $5,211,106 | $3,937,128 | $4,419,121 | $1,114,012 |
| Additional Paid In Capital | $3,296,391 | $3,296,391 | $3,296,391 | $0 |
| Capital Stock | $11,734 | $11,734 | $11,734 | $10,000 |
| Common Stock | $11,734 | $11,734 | $11,734 | $10,000 |
| Long Term Capital Lease Obligation | $12,696 | $39,698 | $0 | - |
| Current Capital Lease Obligation | $28,060 | $24,316 | $0 | - |
| Current Accrued Expenses | $9,656 | $11,684 | $6,995 | $8,714 |
| Dueto Related Parties Current | $0 | $1,587 | $0 | - |
| Net PPE | $385,787 | $382,101 | $406,873 | $515,703 |
| Accumulated Depreciation | $-1,357,327 | $-1,268,011 | $-1,405,542 | $-1,509,747 |
| Gross PPE | $1,743,114 | $1,650,112 | $1,812,415 | $2,025,450 |
| Other Properties | $278,207 | $274,425 | $354,520 | $347,970 |
| Machinery Furniture Equipment | $1,402,928 | $1,313,708 | $1,438,761 | $1,654,656 |
| Buildings And Improvements | $61,979 | $61,979 | $0 | - |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $726,136 | $572,063 | $0 | $438,923 |
| Work In Process | $306 | $0 | - | - |
| Raw Materials | $261,899 | $291,389 | - | - |
| Current Provisions | - | $92,000 | - | - |
| Leases | - | $0 | $19,134 | $22,824 |
| Inventories Adjustments Allowances | - | $-10,221 | $-27,086 | - |
| Other Inventories | - | $861,450 | $381,390 | - |
Fetched: 2026-02-06
Cash Flow Statement (Annual)
| Metric | 2025-02-28 | 2024-02-29 | 2023-02-28 |
|---|---|---|---|
| Free Cash Flow | |||
| Free Cash Flow | $788,821 | $11,987 | $-490,549 |
| Operating Activities | |||
| Operating Cash Flow | $877,834 | $14,242 | $-490,549 |
| Cash Flow From Continuing Operating Activities | $877,834 | $14,242 | $-490,563 |
| Operating Gains Losses | $-5,765 | $-3,916 | $-80,643 |
| Investing Activities | |||
| Capital Expenditure | $-89,013 | $-2,255 | - |
| Investing Cash Flow | $-89,013 | $10,125 | $-529,723 |
| Cash Flow From Continuing Investing Activities | $-89,013 | $10,125 | $-529,723 |
| Net Other Investing Changes | - | $12,380 | $-585,000 |
| Financing Activities | |||
| Financing Cash Flow | $-894,482 | $-8,092 | $3,577,194 |
| Cash Flow From Continuing Financing Activities | $-894,482 | $-8,092 | $3,577,194 |
| Issuance Of Capital Stock | - | $0 | $3,298,125 |
| Net Common Stock Issuance | - | $0 | $3,298,125 |
| Common Stock Issuance | - | $0 | $3,298,125 |
| Other | |||
| Repayment Of Debt | $-895,279 | $-9,680 | $0 |
| Issuance Of Debt | $797 | $1,588 | $279,069 |
| Interest Paid Supplemental Data | $176,416 | $277,230 | $226,814 |
| End Cash Position | $2,769,686 | $2,808,910 | $2,827,457 |
| Beginning Cash Position | $2,808,910 | $2,827,457 | $131,577 |
| Effect Of Exchange Rate Changes | $66,437 | $-34,822 | $138,958 |
| Changes In Cash | $-105,661 | $16,275 | $2,556,922 |
| Net Issuance Payments Of Debt | $-894,482 | $-8,092 | $279,069 |
| Net Long Term Debt Issuance | $-894,482 | $-8,092 | $279,069 |
| Long Term Debt Payments | $-895,279 | $-9,680 | $0 |
| Long Term Debt Issuance | $797 | $1,588 | $279,069 |
| Net PPE Purchase And Sale | $-89,013 | $-2,255 | $55,277 |
| Purchase Of PPE | $-89,013 | $-2,255 | - |
| Taxes Refund Paid | $-266,381 | $-33,036 | $0 |
| Interest Paid Cfo | $0 | $-49,262 | $0 |
| Change In Working Capital | $-1,915,974 | $-500,912 | $-74,108 |
| Change In Payables And Accrued Expense | $226,855 | $621,650 | $-137,708 |
| Change In Prepaid Assets | $-11,944 | $-10,674 | $0 |
| Change In Inventory | $-91,639 | $-480,640 | $84,619 |
| Change In Receivables | $-2,039,246 | $-631,248 | $-21,019 |
| Other Non Cash Items | $-32,030 | $-13,299 | $156,084 |
| Asset Impairment Charge | $0 | $694,145 | $0 |
| Deferred Tax | $864,665 | $236,985 | $-192,700 |
| Deferred Income Tax | $864,665 | $236,985 | $-192,700 |
| Depreciation Amortization Depletion | $73,846 | $88,225 | $53,553 |
| Depreciation And Amortization | $73,846 | $88,225 | $53,553 |
| Depreciation | $73,846 | $88,225 | $53,553 |
| Net Foreign Currency Exchange Gain Loss | $-5,765 | $-3,916 | $-80,643 |
| Net Income From Continuing Operations | $2,159,473 | $-404,688 | $-352,735 |
| Provisionand Write Offof Assets | - | $139,712 | $-169,375 |
| Sale Of PPE | - | - | $55,277 |
Fetched: 2026-02-06